Wilhelmina M. Duivenvoorden
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Comprehensive review of cardiovascular disease in prostate cancer: epidemiology, risk factors, therapeutics and prevention strategies.
Journal: Prostate cancer and prostatic diseases
Published: April 29, 2024
Cardiovascular risk in ADT recipients: does the type of ADT matter?
Journal: Prostate cancer and prostatic diseases
Published: January 24, 2024
Follicle-Stimulating Hormone Exacerbates Cardiovascular Disease in the Presence of Low or Castrate Testosterone Levels.
Journal: JACC. Basic to translational science
Published: October 05, 2023
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy.
Journal: The Journal of urology
Published: January 03, 2022
Correction: Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE-/-:Ins2+/Akita mouse model.
Journal: Prostate cancer and prostatic diseases
Published: August 20, 2021
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.
Journal: The Prostate
Published: June 28, 2021
Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE-/-:Ins2+/Akita mouse model.
Journal: Prostate cancer and prostatic diseases
Published: May 12, 2020
Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease.
Journal: The Journal of urology
Published: June 13, 2019
Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: May 08, 2018
An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.
Journal: International journal of molecular sciences
Published: February 01, 2017
Last Updated: 09/26/2026